Amplifon | AMP - Ebitda

Stock Price
10.93
Daily Change
0.05 0.46%
Monthly
10.09%
Yearly
-44.46%
Q2 Forecast
10.67

Amplifon reported EUR141.76M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Amplifon EUR 141.76M 19.85M Mar/2026
Avanos Medical USD 13M 3M Dec/2025
Brookdale Senior Living USD 105.56M 5.51M Dec/2025
Cencora USD 1.2B 42.41M Dec/2025
Diasorin EUR 90M 2M Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
Enovis USD 103.57M 8.33M Mar/2026
GE HealthCare Technologies USD 1.1B 187M Dec/2025
OPKO Health USD 75.53M 144.7M Sep/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025